A randomized trial of iron depletion in patients with nonalcoholic fatty liver disease and hyperferritinemia

被引:91
作者
Valenti, Luca [1 ]
Fracanzani, Anna Ludovica [1 ]
Dongiovanni, Paola [1 ]
Rovida, Serena [1 ]
Rametta, Raffaela [1 ]
Fatta, Erika [1 ]
Pulixi, Edoardo Alessandro [1 ]
Maggioni, Marco [2 ]
Fargion, Silvia [1 ]
机构
[1] Univ Milan, Fdn IRCCS Ca Granda Osped Policlin, Metab Liver Dis Res Ctr, Dept Pathophysiol & Transplantat, I-20122 Milan, Italy
[2] Fdn IRCCS Ca Granda Osped Policlin, I-20122 Milan, Italy
关键词
Nonalcoholic fatty liver disease; Iron depletion; Randomized controlled trial; Ferritin; INSULIN-RESISTANCE; LIFE-STYLE; HEPATOCELLULAR-CARCINOMA; METABOLIC SYNDROME; CANCER-RISK; OVERLOAD; HEMOCHROMATOSIS; VENESECTION; PHLEBOTOMY; MUTATIONS;
D O I
10.3748/wjg.v20.i11.3002
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
AIM:To compare iron depletion to lifestyle changes alone in patients with severe nonalcoholic fatty liver disease (NAFLD) and hyperferritinemia, a frequent feature associated with more severe liver damage, despite at least 6 mo of lifestyle changes. METHODS:Eligible subjects had to be 18-75 years old who underwent liver biopsy for ultrasonographically detected liver steatosis and hyperferritinemia, ferritin levels >= 250 ng/mL, and NAFLD activity score > 1. Iron depletion had to be achieved by removing 350 cc of blood every 10-15 d according to baseline hemoglobin values and venesection tolerance, until ferritin < 30 ng/mL and/or transferrin saturation (TS) < 25%. Thirty-eight patients were randomized 1:1 to phlebotomy (n = 21) or lifestyle changes alone (n = 17). The main outcome of the study was improvement in liver damage according to the NAFLD activity score at 2 years, secondary outcomes were improvements in liver enzymes [alanine aminotransferases (ALT), aspartate aminotransferase (AST), and gamma-glutamyl-transferases (GGT)]. RESULTS:Phlebotomy was associated with normalization of iron parameters without adverse events. In the 21 patients compliant to the study protocol, the rate of histological improvement was higher in iron depleted vs control subjects (8/12, 67% vs 2/9, 22%, p = 0.039). There was a better improvement in steatosis grade in iron depleted vs control patients (p = 0.02). In patients followed-up at two years (n = 35), ALT, AST, and GGT levels were lower in iron-depleted than in control patients (p < 0.05). The prevalence of subjects with improvement in histological damage or, in the absence of liver biopsy, ALT decrease >= 20% (associated with histological improvement in biopsied patients) was higher in the phlebotomy than in the control arm (p = 0.022). The effect of iron depletion on liver damage improvement as assessed by histology or ALT decrease = 20% was independent of baseline AST/ALT ratio and insulin resistance (p = 0.0001). CONCLUSION:Iron depletion by phlebotomy is likely associated with a higher rate of improvement of histological liver damage than lifestyle changes alone in patients with NAFLD and hyperferritinemia, and with amelioration of liver enzymes. (C) 2014 Baishideng Publishing Group Co., Limited. All rights reserved.
引用
收藏
页码:3002 / 3010
页数:9
相关论文
共 32 条
[1]
BARRY M, 1971, LANCET, V1, P100
[2]
Phase II clinical trial of phlebotomy for non-alcoholic fatty liver disease [J].
Beaton, M. D. ;
Chakrabarti, S. ;
Levstik, M. ;
Speechley, M. ;
Marotta, P. ;
Adams, P. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2013, 37 (07) :720-729
[3]
The burden of liver disease in Europe: A review of available epidemiological data [J].
Blachier, Martin ;
Leleu, Henri ;
Peck-Radosavljevic, Markus ;
Valla, Dominique-Charles ;
Roudot-Thoraval, Francoise .
JOURNAL OF HEPATOLOGY, 2013, 58 (03) :593-608
[4]
Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity [J].
Browning, JD ;
Szczepaniak, LS ;
Dobbins, R ;
Nuremberg, P ;
Horton, JD ;
Cohen, JC ;
Grundy, SM ;
Hobbs, HH .
HEPATOLOGY, 2004, 40 (06) :1387-1395
[5]
Relative contribution of iron burden, HFE mutation and insulin resistance to fibrosis in nonalcoholic fatty liver [J].
Bugianesi, E ;
Manzini, P ;
D'Antico, S ;
Vanni, E ;
Longo, F ;
Leone, N ;
Massarenti, P ;
Piga, A ;
Marchesini, G ;
Rizzetto, M .
HEPATOLOGY, 2004, 39 (01) :179-187
[6]
Expanding the natural history from cryptogenic cirrhosis to of nonalcoholic steatohepatitis: Hepatocellular carcinoma [J].
Bugianesi, E ;
Leone, N ;
Vanni, E ;
Marchesini, G ;
Brunello, F ;
Carucci, P ;
Musso, A ;
De Paolis, P ;
Capussotti, L ;
Salizzoni, M ;
Rizzetto, M .
GASTROENTEROLOGY, 2002, 123 (01) :134-140
[7]
Stage of change and motivation to healthier lifestyle in non-alcoholic fatty liver disease [J].
Centis, Elena ;
Moscatiello, Simona ;
Bugianesi, Elisabetta ;
Bellentani, Stefano ;
Fracanzani, Anna Ludovica ;
Calugi, Simona ;
Petta, Salvatore ;
Dalle Grave, Riccardo ;
Marchesini, Giulio .
JOURNAL OF HEPATOLOGY, 2013, 58 (04) :771-777
[8]
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association [J].
Chalasani, Naga ;
Younossi, Zobair ;
Lavine, Joel E. ;
Diehl, Anna Mae ;
Brunt, Elizabeth M. ;
Cusi, Kenneth ;
Charlton, Michael ;
Sanyal, Arun J. .
HEPATOLOGY, 2012, 55 (06) :2005-2023
[9]
LIVER PATHOLOGY IN GENETIC HEMOCHROMATOSIS - A REVIEW OF 135 HOMOZYGOUS CASES AND THEIR BIOCLINICAL CORRELATIONS [J].
DEUGNIER, YM ;
LOREAL, O ;
TURLIN, B ;
GUYADER, D ;
JOUANOLLE, H ;
MOIRAND, R ;
JACQUELINET, C ;
BRISSOT, P .
GASTROENTEROLOGY, 1992, 102 (06) :2050-2059
[10]
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death [J].
Dixon, Scott J. ;
Lemberg, Kathryn M. ;
Lamprecht, Michael R. ;
Skouta, Rachid ;
Zaitsev, Eleina M. ;
Gleason, Caroline E. ;
Patel, Darpan N. ;
Bauer, Andras J. ;
Cantley, Alexandra M. ;
Yang, Wan Seok ;
Morrison, Barclay, III ;
Stockwell, Brent R. .
CELL, 2012, 149 (05) :1060-1072